Search PubMed⌕ Search

Biomedical subjects

F Fauvel

Publications and source records attributed to F Fauvel.

At least 19 recordsLinked to original sources
PubMed1986

Activation of platelets by microfibrils and collagen. A comparative study.

Previous works demonstrated that microfibrils stimulate blood platelets to aggregate. The present study compares the activation of platelets by human placental and bovine aortic microfibrils and by type III collagen. We studied the morphological changes occurring in in platelets during their activation and aggregation, as well as the kinetics of the release reaction and thromboxane B2 formation. As for collagen, the microfibrils-induced platelet aggregation followed a lag phase, during which progressive emission of pseudopodes and centralization of organelles occurred. Aggregation was associated with secretion of beta-thromboglobulin and adenylic adenylic nucleotides, and with formation of thromboxane B2; it was established that the kinetics of secretion and the aggregation curve were parallel. Microfibrils-induced aggregation was also inhibited by ethylenediamine tetraacetic acid, creatine phosphate-creatine phosphokinase, and aspirin, showing that it was calcium-dependent and required a secretion of ADP and formation of endoperoxide and thromboxane. The response to microfibrils was much more rapid than to collagen; placental microfibrils reacted faster than aortic microfibrils. The requirement of plasma in the microfibrils platelets interaction was confirmed: 10 microliters is the minimal amount of plasma necessary for an aggregation of platelets in 400 microliters of buffer. This fact supports the idea of the existence of two different pathways in the interaction between platelet and the subendothelium, depending on the vascular structure (microfibrils or collagen) involved, even though the sequence of events leading to the formation of an aggregate is similar.

Adenosine Diphosphate↗
PubMed1984

Aortic endothelial cells in culture secrete glycoproteins reacting with blood platelets.

The culture medium of bovine aortic endothelial cells contains proteins which inhibit the aggregation of platelets induced by aortic microfibrils but not by type III collagen. From this medium, fibronectin, thrombospondin and a glycoprotein with MW of 128 Kd (GP 128), similar to a glycoprotein described in a microfibrillar extract from bovine aorta were separated by affinity and ion exchange chromatography. GP 128 was further purified by molecular sieve chromatography on SW 3000 column. GP 128 inhibited the aggregation of platelets by microfibrils. This suggests a role of GP 128 in the platelet/subendothelium interaction.

Amino Acids↗
PubMed1983

[Collagen nonapeptide, a trap for platelets].

Biochemical methods involving chemical and enzymatic cleavage of type III collagen (characteristic of arterial subendothelium) have led to the identification of a nonapeptide common to different overlapping collagen fragments capable of interacting with platelets. This nonapeptide has been synthesized; it specifically inhibits platelet aggregation and secretion of endogenous platelet serotonin by type III collagen from which it originates. Its effect on platelet adhesion is moderate. In view of its specificity in the platelet-collagen interaction, its use as a mean of preventing thrombosis can be envisaged.

Blood Platelets↗
PubMed1983

Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor.

Adult bovine aortic tissue was treated with 6 M guanidinium chloride in the presence of proteinase inhibitors to obtain an extract that was essentially devoid of collagenous components and appeared homogeneous by electron microscopy. When this extract was dispersed by sonication it was found to be a very potent inducer of human platelet aggregation. This interaction required the presence of von Willebrand factor and of its receptor (glycoprotein Ib) on platelet membrane. This was demonstrated by the fact that the aggregation of normal blood platelets resuspended in plasmas deficient in von Willebrand factor was significantly diminished as compared to aggregation in control plasma. Moreover, this aggregation was inhibited by a monoclonal antibody, IgG AN51, to platelet glycoprotein Ib. These studies provide direct biochemical evidence for the existence of a thrombogenic constituent of the vessel wall that is noncollagenous and von Willebrand factor-dependent.

Amino Acids↗
PubMed1983

Nonenzymatic glycosylation of collagen in diabetes: incidence on increased normal platelet aggregation.

The effect of normal and nonenzymatically glycosylated rat type I acid-soluble collagen on normal human platelets was investigated. Glycosylated collagen was obtained either after in vitro incubation with glucose or from rats made diabetic by streptozotocin. The amount of nonenzymatically bound glucose was as follows: normal 2.3, diabetic 7.6 and in vitro glycosylated collagen 9.0 nmol/mg. When investigated under conditions leading to identical diameters and molecular packings for all the samples, the aggregation potency was markedly stronger for diabetic and glycosylated collagens than for normal ones. These results show the potential role of this posttranslational modification of collagen which can be considered as a risk factor in the thrombotic pathogeny of diabetes.

Animals↗
PubMed1983

The molecular interaction between platelet and vascular wall.

Two different subendothelial macromolecules have been identified as being thrombogenic: collagen and the microfibrils associated with elastin. The interaction between platelets and collagen involves the binding of platelet membrane receptors by numerous sites repeatedly staggered along a collagen fiber: this explains why the preservation of ordered structures (quaternary and tertiary structures) is so important in the reactivity of collagen towards platelets. In the case of Type III collagen, a nonapeptide has been identified as possibly being part of these repetitive sites. The microfibrils have not yet been characterized, although the biochemical data presently available show that they are acidic glycoproteins resistant to collagenase. Microfibrils extracted from human placenta or bovine aorta induce the aggregation of platelets in a reaction which involves platelet glycoprotein Ib and FVIII/vWF. A general model proposed for explaining platelet adhesion to subendothelium suggests that two different mechanisms should be envisaged depending on the thrombogenic macromolecules (collagen, microfibrils) involved.

Binding Sites↗
PubMed1982

Histochemical and ultrastructural characterization of subendothelial glycoprotein microfibrils interacting with platelets.

The interaction of human blood platelets with collagenase-treated rabbit subendothelium was studied by histochemical ultrastructural methods and by morphometric semi-quantitative analysis. Aortas were deendothelialized and incubated: 1) with a highly purified bacterial collagenase whose specificity was controlled; and 2) with the same collagenase followed by chymotrypsin. For histochemical studies, tannic acid, ruthenium red, and peroxidase-labeled Ricinus communis and concanavalin A were used. Electron microscopy showed that after digestion of fibrillar collagen by collagenase, adherent and aggregated platelets were observed on Ricinus communis-, concanavalin A-, and ruthenium red-positive glycoprotein microfibrils. After successive incubation with collagenase and chymotrypsin, the microfibrils disappeared. No platelets were observed on the remnant amorphous elastin. Morphometric analysis confirmed the interaction of platelets with collagenase-treated subendothelium. In addition, glycoproteins were extracted from collagenase-treated rabbit aortas using 5 M guanidine. Using an in vitro quantitative test, significant platelet adhesion to these glycoproteins was observed. Our results show an interaction between platelets and noncollagenic glycoprotein microfibrils.

Animals↗
PubMed1982

[Thrombogenicity of the vessel: role of microfibrils and of collagen].

Thrombogenicity of the vessel wall: role of the microfibrils and collagen. The study of platelet adhesion to rabbit aortic subendothelium preincubated with highly specific collagenase has revealed that platelets adhere to the microfibrils of the elastic lamina. To certify that an interaction between microfibrils and platelets can occur, microfibrils from two different origins were isolated: placental microfibrils extracted from the villi of human placenta, and aortic microfibrils extracted from adult bovine aorta. Both preparations were histologically homogeneous, and differed in their amino acid composition with an acidic character more pronounced for placental than for aortic microfibrils. Both preparations were able to induce platelet aggregation in plasma, but not after platelet isolation and resuspension in buffer. An interesting feature was the fact that when normal platelets were isolated, washed and resuspended in plasma from severe VWD patients, they were not aggregated by placental or aortic microfibrils. This defect was corrected after perfusion of cryoprecipitate to one patient. Moreover, monoclonal antibody directed against platelet glycoprotein Ib inhibited the aggregation of platelets to microfibrils, not to collagen; this suggested that an axis platelet GPI-FVIII/VWF-microfibrils could represent a pathway for platelet/subendothelium interaction. The adhesion of platelets to collagen seems to involve the staggering of a short amino acid sequence along a collagen fibre. This possibility arises from the requirement for the preservation of the quaternary structure of collagen in the induction of platelet adhesion/aggregation in vitro, and also from the identification and synthesis of a nonapeptide derived from type III collagen, which is also to specifically inhibit the aggregation of platelets by collagen, following its binding to platelet membrane.

Animals↗
PubMed1981

[The adhesion of blood platelets to collagen: molecular features of collagen (author's transl)].

This review deals with some structural features of the collagen molecules involved in the adhesion of platelets representing the initial step of hemostasis, thrombosis, and (partly) atherosclerosis. The adhesion occurs at the level of a vascular lesion or deendothelialized area, whatever the genetic type of collagen. In vitro experiments with purified collagens have shown that vascular interstitial collagens (types I and III, the latter present in subendothelium) as well as basement membrane-derived collagens (types IV and V) induce an adhesion of platelets, provided that an ordered arrangement linked to the quaternary and tertiary structures of their molecule is preserved. Whatever the quaternary structure, the important point seems to be the size of the fibers and more precisely the availability of an optimal number of adhesion sites on multimerized fibers. Various direct or indirect proofs (for example, the occurrence of the impairment of collagen multimerization on platelet adhesion/aggregation) are reviewed. Our recent studies on interstitial collagens have shown the involvement of certain specific amino-acid sequences obtained after cyanogen bromide cleavage of collagen. These are the C-terminal alpha1 (I) CB6 peptide of the alpha 1 chains of type I collagen (216 amino acids) and the central alpha1 (III) CB4 peptide from type III collagen (149 amino acids) Cleavage of this last peptide by chymotrypsin, hydroxylamine, and trypsin has suggested the possibility that a nonapeptide (sequence gly-lys-hyp-gly-glu-hyp-gly-pro-lys) is a minimum site of adhesion for platelets. This assumption has been reinforced by the fact that a synthetic nonapeptide with this sequence specifically inhibits the aggregation of platelets to collagen in vitro. The adhesion of platelets may consequently be due to the repetitive staggering of short amino acid sequences (such as this nonapeptide from type III collagen) along the rigid structure formed by a multimerized collagen fiber.

Basement Membrane↗
PubMed1981

[Relation between the wall structure and modifications of the blood content (author's transl)].

In view of its anatomical position, physical characteristics and metabolism, the endothelial cell plays a major part in maintaining the integrity of the vascular system and in the relation between the blood content, both plasma and blood cells, and the wall structure. Where this continuous single layer undergoes anatomical or functional changes, a new equilibrium is set up, an equilibrium which is multifactorial and dynamic. It is governed by the vascular and blood components and by their interrelation; it varies as a function of time and of the biorheological conditions. The interrelationship between the blood content and the wall plays an important part in vascular pathology, especially of the degenerative and thrombotic type. A better understanding of these factors will enhance the possibility of preventing atherogenesis and lay the basis for a coherent and effective therapeutic attitude thrombosis.

Blood Vessels↗
PubMed1979

[Arterial subendothelial structures: anatomy, biochemistry, functions].

This review summarizes the main structural and biochemical features of the fibrillar constituents of the subendothelial layers of the arterial wall. Several constituents are directly identified by various histochemical methods and electron-microscopic studies. (1) The microfibrils (MF), stained by tannic acid, cationic stains such as ruthenium red, and various peroxidase-labeled lectins are mostly found in association with elastin within the internal elastic lamina (IEL). They have been characterized by chemical analysis as acidic glycoproteins, hydrolyzed by a variety of proteases, but resistant to collagenases. The endothelial cells seem to participate in their biosynthesis. (2) Elastin (El), which is the main constituent of the IEL, forms a wide, concentric, electron-lucent, tannic-acid-stainable zone. Fibrous El results from the association of tropoelastin (or proelastin) molecules by intermolecular cross-linkage. During the elastigenesis, this cross-linkage occurs directly between tropoelastin molecules which have been previously sterically oriented by the MF probably synthetized by the same cells (smooth muscle cells and possibly endothelial cells). (3) Interstitial collagen forms sparse fibers characterized by their cross-striation (with a periodicity of 640 A). They are relatively resistant to most proteolytic enzymes, except collagenases. They result from the intermolecular cross-linkage of rigid molecules, resulting themselves from the intramolecular cross-linkage of three helical alpha chains as a triple helix. The interstitial subendothelial collagen has been identified by indirect immunofluorescence as a type III collagen. The same technique has also been used to detect type IV collagen and fibronectin. This glycoprotein could play a role in the attachment of the endothelial cells to the fibrillar network of the subendothelium, despite an affinity which is greater toward denatured collagen than toward native collagen. One of the most important functions of the subendothelium is its role in thrombogenesis, in which both MF and collagen are involved. In type III collagen, this property is linked to the preservation of an ordered structure in which a 9-amino acids fragment, localized in the central part of each chain, could bear an adhesion site.

Animals↗
PubMed1979

Specific and quantitative method for estimation of platelet adhesion to fibrillar collagen.

A quantitative method (Sepharose test) was devised to measure the adhesion of blood platelets to fibrillar collagen. [14C]5HT-labeled platelets were isolated from plasma, resuspended in EDTA buffer, and incubated with buffer (control) or with fibrillar collagen for 150 sec at 33 degrees C. The mixtures were then filtered through Sepharose 2B columns. In controls the platelets were rapidly eluted, and this was confirmed after 51Cr labeling. [C]5HT was recovered in two stages: 60% with the platelets and 40% retarded, as free 5HT. After incubation with fibrillar collagen (50 micrograms), platelets were retained with the fibrils on the top of the column, and only free [14C]5HT (released from the platelets) was eluted. The percentage of adhesion depended on the number of platelets, the amount of collagen, its degree of polymerization, and the time of incubation at 33 degrees C. [14C]5HT release was markedly diminished when both incubation and filtration were performed at low temperature. ASA, used either in vitro or in vivo in rabbits, did not change the percentage of adhesion but significantly diminished the total amount of [14C]5HT eluted. This method offers a quantitative and reproducible system for the differentiation of adhesion and release, independent of platelet aggregation.

Animals↗